Intra-arterial chemotherapy in the treatment of inoperable patients with Klatskin tumor: preliminary results

Aleksey V. Kozlov , Pavel G. Tarazov , Aleksey A. Polikarpov , Andrey V. Moiseenko , Anastasia S. Turlak

Journal of Clinical Practice ›› 2022, Vol. 13 ›› Issue (3) : 25 -31.

PDF
Journal of Clinical Practice ›› 2022, Vol. 13 ›› Issue (3) : 25 -31. DOI: 10.17816/clinpract109310
Original Study Articles
research-article

Intra-arterial chemotherapy in the treatment of inoperable patients with Klatskin tumor: preliminary results

Author information +
History +
PDF

Abstract

Background: Surgical resection is the treatment of choice for Klatskin tumor, when possible, but unfortunately, many patients present with the late-stage and unresectable disease. A large number of studies have confirmed that arterial chemotherapy is safe and effective for the palliative treatment of primary and secondary hepatic malignancies. Aim: To evaluate the safety and efficacy of hepatic arterial infusion in patients with Klatskin tumor. Methods: Between 2010 and 2021, 14 of 119 patients with inoperable Klatskin tumor were treated with hepatic arterial infusion of GemCis at the A.M. Granov RRCRST. All the patients had obstructive jaundice and received percutaneous transhepatic biliary drainage. Chemotherapy was started when the serum bilirubin level became normal (averagely on the 106th day from percutaneous transhepatic biliary drainage). In total, 19 (from 1 to 4 per patient) hepatic arterial infusion cycles were performed. Results: Percutaneous transhepatic biliary drainage complications such as cholangitis (n=2) and local peritonitis (n=1) developed in 3 patients (21%) and were successfully treated using minimally invasive techniques. The toxicity of chemotherapy was observed in 8 of 14 patients (57%): I–II degree hematological toxicity (43%) and gastrointestinal toxicity (50%); these complications were cured by medical therapy. The overall mean survival was 286 days (9.6 months), the median survival was 283 days (9.4 months). Conclusions: Our preliminary results show that hepatic arterial infusion in patients with Klatskin tumor is safe, but has limited effectiveness. The combination of arterial infusion with other methods such as radiotherapy, intra-ductal photodynamic therapy, radiofrequency ablation, target therapy, should be investigated.

Keywords

cholangiocarcinoma / Klatskin tumor / angiography / regional chemotherapy / intra-arterial infusion

Cite this article

Download citation ▾
Aleksey V. Kozlov, Pavel G. Tarazov, Aleksey A. Polikarpov, Andrey V. Moiseenko, Anastasia S. Turlak. Intra-arterial chemotherapy in the treatment of inoperable patients with Klatskin tumor: preliminary results. Journal of Clinical Practice, 2022, 13(3): 25-31 DOI:10.17816/clinpract109310

登录浏览全文

4963

注册一个新账户 忘记密码

References

Funding

Государственное задание «Разработка методики внутрипротоковой фотодинамической терапии и внутриартериальной регионарной химиотерапии для лечения пациентов с нерезектабельными опухолями Клацкина»State assignment «Development of a technique of photodynamic therapy and intra-arterial chemotherapy for the treatment of patients with unresectable Klatskin tumors»(№ 056-00102-21)

RIGHTS & PERMISSIONS

Kozlov A.V., Tarazov P.G., Polikarpov A.A., Moiseenko A.V., Turlak A.S.

AI Summary AI Mindmap
PDF

60

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/